Analysis on the Barriers and Countermeasures of Chinese Medicine Enterprises for Countries along the Belt and Road
- https://doi.org/10.2991/isbcd-18.2018.63How to use a DOI?
- Belt and Road; Chinese medicine companies; technical barriers
Culture is the bridge connecting countries in the construction of The Belt and Road Initiative. Chinese medicine, one of the essences of traditional Chinese culture, not only shoulders the responsibility of such bridges and bonds, but also faces an excellent opportunity to go with the The Belt and Road counterparts to the world. The Chinese medicine industry is a traditional industry with comparative advantages in China. However, for a long time, the share of traditional Chinese medicine exports in the international market has been very low. This article first analyzes the status of Chinese medicine exports, which can analyze the problems existing in the export of Chinese medicine, and finally from the government and the enterprise level to propose countermeasures against the barriers.
- © 2018, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - Wannan Wang AU - Yongsong Liu AU - Yunlong Duan PY - 2018/10 DA - 2018/10 TI - Analysis on the Barriers and Countermeasures of Chinese Medicine Enterprises for Countries along the Belt and Road BT - Proceedings of the 3rd International Symposium on Asian B&R Conference on International Business Cooperation (ISBCD 2018) PB - Atlantis Press SP - 316 EP - 322 SN - 2352-5428 UR - https://doi.org/10.2991/isbcd-18.2018.63 DO - https://doi.org/10.2991/isbcd-18.2018.63 ID - Wang2018/10 ER -